Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 63,868 | 53,853 | 56,886 | 55,877 | 59,711 |
| Cost of Goods | 46,290 | 40,535 | 43,606 | 43,916 | 47,920 |
| Gross Profit | 17,578 | 13,318 | 13,280 | 11,961 | 11,791 |
| Operating Expenses | 21,616 | 24,113 | 21,147 | 19,902 | 20,528 |
| Operating Income | -3,748 | -10,260 | -7,261 | -7,025 | -7,817 |
| Interest Expense | 232 | 210 | 341 | -551 | 504 |
| Other Income | -296 | 241 | 1,405 | 657 | 337 |
| Pre-tax Income | -4,276 | -10,229 | -6,197 | -5,817 | -7,984 |
| Income Tax | -1,268 | -3,582 | -5,532 | -3,296 | -2,605 |
| Net Income Continuous | -3,008 | -6,647 | -665 | -2,521 | -5,379 |
| Net Income | $-3,008 | $-6,647 | $-665 | $-2,521 | $-5,379 |
| EPS Basic Total Ops | -0.07 | -0.15 | -0.01 | -0.06 | -0.12 |
| EPS Basic Continuous Ops | -0.07 | -0.15 | -0.01 | -0.06 | -0.12 |
| EPS Diluted Total Ops | -0.07 | -0.15 | -0.01 | -0.06 | -0.12 |
| EPS Diluted Continuous Ops | -0.07 | -0.15 | -0.01 | -0.06 | -0.12 |
| EBITDA(a) | $-385 | $-6,901 | $-4,009 | $-3,249 | $-4,137 |